Biotage Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Biotage has a total shareholder equity of SEK3.8B and total debt of SEK150.0M, which brings its debt-to-equity ratio to 3.9%. Its total assets and total liabilities are SEK4.9B and SEK1.1B respectively. Biotage's EBIT is SEK369.0M making its interest coverage ratio 23.1. It has cash and short-term investments of SEK370.0M.
Anahtar bilgiler
3.9%
Borç/özkaynak oranı
SEK 150.00m
Borç
| Faiz karşılama oranı | 23.1x |
| Nakit | SEK 370.00m |
| Eşitlik | SEK 3.81b |
| Toplam yükümlülükler | SEK 1.06b |
| Toplam varlıklar | SEK 4.87b |
Son finansal sağlık güncellemeleri
Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet
Feb 08
Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?
Jul 12These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely
Mar 12Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly
Dec 03Biotage (STO:BIOT) Could Easily Take On More Debt
Sep 03Recent updates
Earnings Miss: Biotage AB (publ) Missed EPS By 15% And Analysts Are Revising Their Forecasts
Oct 26Investors Interested In Biotage AB (publ)'s (STO:BIOT) Earnings
Sep 17Biotage AB (publ) Just Missed EPS By 7.7%: Here's What Analysts Think Will Happen Next
Jul 19Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 39%?
Jun 08Is Biotage AB (publ) (STO:BIOT) Potentially Undervalued?
May 21Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates
Apr 28Biotage's (STO:BIOT) Dividend Will Be SEK1.60
Apr 17Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next
Apr 08Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Apr 03Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Mar 04Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)
Feb 22Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%
Feb 21Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 18Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet
Feb 08Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)
Jan 07At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?
Dec 08Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)
Oct 27Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?
Jul 12An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued
Jun 08Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth
May 24Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 05These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely
Mar 12Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?
Feb 21Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?
Jan 06Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly
Dec 03Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?
Oct 27Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)
Oct 07Biotage (STO:BIOT) Could Easily Take On More Debt
Sep 03Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?
Jul 10A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)
Jun 25Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?
May 28Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 23Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: BIOT's short term assets (SEK1.2B) exceed its short term liabilities (SEK648.0M).
Uzun Vadeli Yükümlülükler: BIOT's short term assets (SEK1.2B) exceed its long term liabilities (SEK407.0M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: BIOT has more cash than its total debt.
Borcun Azaltılması: BIOT's debt to equity ratio has reduced from 12.6% to 3.9% over the past 5 years.
Borç Kapsamı: BIOT's debt is well covered by operating cash flow (270.7%).
Faiz Kapsamı: BIOT's interest payments on its debt are well covered by EBIT (23.1x coverage).